Avoiding bias in trials in which allocation ratio is varied

Journal of the Royal Society of Medicine

Volumn 111, Issue 4, 2018, Pages 143-144

  Altman, Douglas G ^a  

^a UNIVERSITY OF OXFORD   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

MINERAL WATER; PLACEBO; PRELADENANT;

ALCOHOL ABSTINENCE; CLINICAL TRIAL (TOPIC); DIABETES MELLITUS; HUMAN; INSOMNIA; NOTE; PARKINSON DISEASE; RANDOMIZATION; RED WINE; SYSTEMATIC ERROR; WHITE WINE; PROCEDURES; RANDOMIZED CONTROLLED TRIAL (TOPIC); SELECTION BIAS;

HUMANS; RANDOM ALLOCATION; RANDOMIZED CONTROLLED TRIALS AS TOPIC; SELECTION BIAS;

EID: 85045445003     PISSN: 01410768     EISSN: 17581095     Source Type: Journal    
DOI: 10.1177/0141076818764320     Document Type: Note

References (6)

1. Garland SN, Carlson LE, Stephens AJ, Antle MC, Samuels C, Campbell TS. Mindfulness-based stress reduction compared with cognitive behavioral therapy for the treatment of insomnia comorbid with cancer: a randomized, partially blinded, noninferiority trial. J Clin Oncol 2014; 32: 449–457.
2. Armitage P, Borchgrevink CF. Prevention of recurrences of myocardial infarction. Comments on a previous article. Arch Intern Med 1966; 118: 270–274.
3. Gepner Y, Golan R, Harman-Boehm I, Henkin Y, Schwarzfuchs D, Shelef I, Effects of initiating moderate alcohol intake on cardiometabolic risk in adults with Type 2 diabetes: a 2-year randomized, controlled trial. Ann Intern Med 2015; 163: 569–579.
4. Altman DG. Moderate alcohol intake and cardiometabolic risk in adults with type 2 diabetes. Ann Intern Med 2016; 165: 67–68.
5. Cohen DR, Todd S, Gregory WM, Brown JM. Adding a treatment arm to an ongoing clinical trial: a review of methodology and practice. Trials 2015; 16: 179–179.
6. Hauser RA, Cantillon M, Pourcher E, Micheli F, Mok V, Onofrj M, Preladenant in patients with Parkinson’s disease and motor fluctuations: a phase 2, double-blind, randomised trial. Lancet Neurol 2011; 10: 221–229.